• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 11
  • 8
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1

PRICE

5
5
27
29

PUBLISHED

0
4
23
29

PRODUCT TYPE

27
2

Search "Hemispherx Biopharma Inc-Therapeutic Competitors" returned 29 results.

PRODUCT TITLE
Competitor Analysis: Interferon Competitor Analysis: Interferon - Product Thumbnail Image

Competitor Analysis: Interferon

The Competitive Intelligence Report Interferon as of April 2014 provides a competitor analysis in the product portfolios and development pipelines of novel recombinant and natural interferon alpha,...

April 2013
FROM

Novelos Therapeutics, Inc. (NVLT) - Financial and Strategic SWOT Analysis Review

Summary Novelos Therapeutics, Inc. (Novelos) is a US-based pharmaceutical company. It undertakes the development of novel drugs for the treatment and diagnosis of cancer. The company's therapeutic...

April 2013
FROM

Fatigue - Pipeline Review, H2 2014

Fatigue - Pipeline Review, H2 2014 Summary This, ‘Fatigue - Pipeline Review, H2 2014’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

August 2014
FROM

Fatigue - Pipeline Review, H1 2014

Fatigue - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Fatigue - Pipeline Review, H1 2014’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive...

March 2014
FROM

Peritoneal Cancer - Pipeline Review, H1 2015

Peritoneal Cancer - Pipeline Review, H1 2015 Summary This, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

January 2015
FROM
Coronavirus Infection - Pipeline Review, H2 2014 Coronavirus Infection - Pipeline Review, H2 2014 - Product Thumbnail Image

Coronavirus Infection - Pipeline Review, H2 2014

Coronavirus Infection - Pipeline Review, H2 2014 Summary This, ‘Coronavirus Infection - Pipeline Review, H2 2014’, provides an overview of the Coronavirus Infection’s therapeutic pipeline. This...

November 2014
FROM

Fatigue - Pipeline Review, H1 2015

Fatigue - Pipeline Review, H1 2015 Summary This, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

West Nile Virus Infections - Pipeline Review, H1 2014

West Nile Virus Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H1 2014’, provides an overview of the West Nile Virus Infections’s...

May 2014
FROM

Influenza A Infections - Pipeline Review, H1 2014

Influenza A Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Influenza A Infections - Pipeline Review, H1 2014’, provides an overview of the Influenza A Infections’s therapeutic...

March 2014
FROM

Renal Cell Carcinoma - Pipeline Review, H2 2014

Renal Cell Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Renal Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report...

September 2014
FROM

Ovarian Cancer - Pipeline Review, H2 2014

Ovarian Cancer - Pipeline Review, H2 2014 Summary This, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Influenza A Infections - Pipeline Review, H2 2014

Influenza A Infections - Pipeline Review, H2 2014 Summary This, ‘Influenza A Infections - Pipeline Review, H2 2014’, provides an overview of the Influenza A Infections’s therapeutic pipeline. This...

September 2014
FROM

SciClone Pharmaceuticals, Inc. (SCLN) - Financial and Strategic SWOT Analysis Review

SciClone Pharmaceuticals, Inc. (SCLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

January 2015
FROM

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review

Amarillo Biosciences, Inc. (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014

Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2014’, provides an overview of the Genital...

June 2014
FROM

Hepatitis C - Pipeline Review, H1 2014

Hepatitis C - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides...

February 2014
FROM

Multiple Sclerosis - Pipeline Review, H1 2014

Multiple Sclerosis - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This...

March 2014
FROM

Hemorrhagic Fever - Pipeline Review, H2 2014

Hemorrhagic Fever - Pipeline Review, H2 2014 Summary This, ‘Hemorrhagic Fever - Pipeline Review, H2 2014’, provides an overview of the Hemorrhagic Fever’s therapeutic pipeline. This report provides...

November 2014
FROM

Peritoneal Cancer - Pipeline Review, H2 2014

Peritoneal Cancer - Pipeline Review, H2 2014 Summary This, ‘Peritoneal Cancer - Pipeline Review, H2 2014’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM
Loading Indicator

Our Clients

Procter & Gamble Co. Western Union Company Volvo Car Corporation Morgan Stanley SAP SE LG Corporation Roche Diagnostics Ltd.